Tirzepatide , originally approved for managing type 2 diabetes, has emerged as a promising medication in our comprehensive approach to treating obesity and supporting sustainable weight loss
Depo-Provera MDL Leadership Reappointed Depo-Provera Lawsuit Update | April 6, 2026 The Depo-Provera multidistrict litigation (MDL) continues to move forward, with the court reappointing the leadership team representing the victims
Eosinophilic cytoplasmic inclusions may be found occasionally within hepatocytes
Prevention of early alzheimers disease by erinacine a-enriched hericium erinaceus mycelia pilot double-blind placebo-controlled study
If youre not losing weight on tirzepatide, common reasons include being on a starting dose, consuming more calories than expected, not getting enough protein, lack of exercise, poor sleep, chronic stress, underlying hormonal imbalances, medication interactions, or experiencing a normal weight loss plateau
They affect how you walk, stand, and even how you feel about your feet
